Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Glaxosmithkline plc symbols : BNTX save search
Global mRNA Vaccine Market Research Report 2023-2028: COVID-19 Success Opens New Avenues with with 444 Ongoing Clinical Studies Worldwide
Published: 2023-11-08 (Crawled : 03:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.91%
H: 0.0%
C: 0.0%
VERV | $6.66 -1.19% -1.2% 1.2M
|
Professional, Scientific, and T...
|
| O: 0.37%
H: 0.64%
C: -10.76%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.46%
H: 0.46%
C: -0.23%
MRNA S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: -0.01%
H: 0.03%
C: -3.14%
CVAC | News | $2.44 -5.06% -5.33% 710K
|
Health Technology
|
| O: 0.91%
H: 1.08%
C: -1.44%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: 0.13%
H: 0.08%
C: -2.81%
ARCT 4 | $26.31 -4.81% -5.06% 610K
|
Health Technology
|
| O: -0.36%
H: 0.79%
C: -0.61%
covid-19 success report vaccine mrna worldwide ongoing research global market
Global Peptide Therapeutics Market Report 2023: Increasing Prevalence of Cancer and Metabolic Disorders Drives Growth
Published: 2023-06-08 (Crawled : 02:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 0.07%
H: 0.0%
C: -1.7%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.32%
H: 0.0%
C: -0.62%
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: -0.62%
H: 0.88%
C: 0.81%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 1.26%
H: 1.08%
C: 0.91%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.41%
H: 0.68%
C: 0.64%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.11%
H: 2.66%
C: 2.24%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.28%
H: 0.42%
C: -0.05%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: 0.39%
H: 0.15%
C: -0.79%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -0.23%
H: 1.83%
C: 1.52%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.0%
H: 0.28%
C: -0.23%
metabolic report cancer global therapeutics growth market
CureVac gibt Entwicklungen im Patentrechtsstreit mit Pfizer/BioNTech bekannt
Published: 2023-05-19 (Crawled : 11:00) - curevac.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.67%
H: 1.53%
C: 0.28%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.14%
H: 1.45%
C: 1.28%
CVAC | News | $2.44 -5.06% -5.33% 710K
|
Health Technology
|
| O: 0.91%
H: 4.53%
C: 2.49%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: 0.37%
H: 1.96%
C: 1.09%
Global Bioengineered Protein Drugs Markets Report 2023: A $521.3 Billion Market by 2027 Featuring AbbVie, AstraZeneca, GlaxoSmithKline, Bristol-Myers Squibb, Pfizer, Merck and Sanofi
Published: 2023-04-20 (Crawled : 01:00) - prnewswire.com
CMXHF | $172.54 -19.21% 50
|
n/a
|
| O: -1.07%
H: 1.56%
C: -0.01%
CSLLY | $87.96 3.3% 45K
|
n/a
|
| O: 0.23%
H: 0.39%
C: -0.18%
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: -0.68%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: -0.53%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.61%
H: 0.0%
C: 0.0%
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 0.33%
H: 0.36%
C: -0.13%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.34%
H: 0.28%
C: 0.25%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.06%
H: 0.86%
C: 0.71%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.24%
H: 0.0%
C: -1.03%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.02%
H: 0.37%
C: 0.35%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: -0.85%
H: 1.51%
C: 0.15%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 0.05%
H: 0.11%
C: -0.47%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.04%
H: 0.11%
C: -1.08%
ADMA 4 | $6.21 2.82% 2.74% 3M
|
Health Technology
|
| O: -0.87%
H: 1.17%
C: 0.29%
report merck global protein sanofi market
mRNA Vaccines and Therapeutics Global Market Report 2023: Sector to Reach $66.2 Billion by 2028 at a 2.8% CAGR
Published: 2023-03-02 (Crawled : 23:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.09%
H: 1.57%
C: 1.51%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.38%
H: 0.65%
C: 0.61%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: 0.37%
H: 2.61%
C: 1.81%
global report mrna therapeutics market
PFIZER REPORTS RECORD FULL-YEAR 2022 RESULTS AND PROVIDES FULL-YEAR 2023 FINANCIAL GUIDANCE
Published: 2023-01-31 (Crawled : 13:00) - biospace.com/
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 2.04%
H: 0.0%
C: -3.67%
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: -1.26%
H: 2.97%
C: 2.7%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.85%
H: 0.31%
C: -0.45%
BHVN | News 0 d | $42.16 -4.25% 0.85% 3.7M
|
Health Technology
|
| O: -0.48%
H: 4.49%
C: 3.24%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: -1.74%
H: 4.84%
C: 3.88%
BEAM | $24.33 0.08% 0.08% 1.7M
|
Health Technology
|
| O: 0.21%
H: 4.84%
C: 2.99%
financial results
Pfizer Reports Strong Third-quarter 2022 Results and Raises 2022 Outlook
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
HLN | $8.13 0.25% -0.98% 4.8M
|
n/a
|
| O: 0.16%
H: 1.79%
C: 0.16%
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.68%
H: 0.0%
C: -0.27%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 7.74%
H: 0.17%
C: 0.17%
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: 3.11%
H: 0.88%
C: 0.02%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 1.72%
H: 0.39%
C: -0.83%
BHVN | News 0 d | $42.16 -4.25% 0.85% 3.7M
|
Health Technology
|
| O: 1.81%
H: 3.08%
C: -0.65%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: 4.54%
H: 4.25%
C: 0.13%
BEAM | $24.33 0.08% 0.08% 1.7M
|
Health Technology
|
| O: 3.25%
H: 1.41%
C: -2.48%
ARVN | $34.3 2.54% 2.48% 800K
|
Health Technology
|
| O: 1.49%
H: 3.25%
C: 1.68%
results
CureVac veröffentlicht Finanzergebnisse für das zweite Quartal und erste Halbjahr 2022 und informiert über seine Geschäftsentwicklung
Published: 2022-08-18 (Crawled : 12:00) - curevac.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -3.07%
H: 9.03%
C: 4.86%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.32%
H: 0.03%
C: -0.98%
CVAC | News | $2.44 -5.06% -5.33% 710K
|
Health Technology
|
| O: -0.61%
H: 1.64%
C: -4.58%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: -0.21%
H: 0.3%
C: -2.71%
CureVac reicht in Deutschland Klage gegen BioNTech wegen Patentrechtsverletzung ein
Published: 2022-07-05 (Crawled : 11:00) - curevac.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.47%
H: 2.26%
C: -1.71%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -1.33%
H: 0.36%
C: 0.3%
CVAC | News | $2.44 -5.06% -5.33% 710K
|
Health Technology
|
| O: 0.39%
H: 3.11%
C: -1.43%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: -3.89%
H: 7.56%
C: 6.38%
PFIZER REPORTS THIRD-QUARTER 2021 RESULTS
Published: 2021-11-02 (Crawled : 13:00) - biospace.com/
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.14%
H: 0.94%
C: -1.98%
ALPMY | $9.46 -1.11% 500K
|
Manufacturing
|
| O: -1.58%
H: 0.42%
C: 0.24%
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: 3.46%
H: 0.7%
C: -0.09%
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: 2.06%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 1.16%
H: 0.75%
C: -0.19%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -1.55%
H: 0.0%
C: 0.0%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: 0.13%
H: 3.09%
C: 2.62%
ARVN | $34.3 2.54% 2.48% 800K
|
Health Technology
|
| O: 1.4%
H: 4.09%
C: 4.07%
results
COVID-19 Welcomes a New Era in Vaccinology. mRNA Based Vaccines to Reach US$127.3 Billion by the Year 2027
Published: 2021-06-29 (Crawled : 13:00) - prnewswire.com
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.23%
H: 0.33%
C: -0.05%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: -0.94%
H: 2.51%
C: 0.78%
covid vaccine
Worldwide mRNA Vaccines and Therapeutics Industry to 2031 - Featuring Arcturus Therapeutics Holdings, BioNTech and CureVac Among Others
Published: 2021-06-01 (Crawled : 15:00) - prnewswire.com
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.13%
H: 0.08%
C: -1.21%
MRNA S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: -0.5%
H: 0.65%
C: 0.32%
CVAC | News | $2.44 -5.06% -5.33% 710K
|
Health Technology
|
| O: -5.44%
H: 3.4%
C: 2.71%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: 0.28%
H: 2.56%
C: 0.77%
ARCT 4 | $26.31 -4.81% -5.06% 610K
|
Health Technology
|
| O: 1.3%
H: 1.69%
C: 1.15%
vaccine
Global mRNA Vaccines Market Report 2021-2027: COVID-19 Vaccine Segment is Projected to Record a -5.9% CAGR and Shrink to a Market Size of $22.2 Billion
Published: 2021-03-10 (Crawled : 14:34) - prnewswire.com
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 1.45%
H: 0.39%
C: -0.03%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: 4.46%
H: 1.19%
C: -2.75%
covid vaccine
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.